Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Aligos Therapeutics, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: March 10, 2022 |
|
|
|
| By: |
| /s/ Lesley Ann Calhoun |
|
|
| Lesley Ann Calhoun |
|
|
| Executive Vice President, Chief Financial Officer |
|
|
| (Principal Financial and Accounting Officer) |